Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Total Liabilities (2020 - 2026)

Core Scientific has reported Total Liabilities over the past 7 years, most recently at $4.4 billion for Q1 2026.

  • Quarterly results put Total Liabilities at $4.4 billion for Q1 2026, up 142.14% from a year ago — trailing twelve months through Mar 2026 was $4.4 billion (up 142.14% YoY), and the annual figure for FY2025 was $3.3 billion, up 36.85%.
  • Total Liabilities reached $4.4 billion in Q1 2026 per CORZ's latest filing, up from $3.3 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $4.4 billion in Q1 2026 and bottomed at $1.1 billion in Q3 2023.
  • Median Total Liabilities over the past 5 years was $1.6 billion (2022), compared with a mean of $2.0 billion.
  • The largest annual shift saw Total Liabilities soared 5198.54% in 2022 before it dropped 26.62% in 2023.
  • Over 5 years, Total Liabilities stood at $1.2 billion in 2022, then increased by 7.56% to $1.3 billion in 2023, then soared by 84.78% to $2.4 billion in 2024, then surged by 36.85% to $3.3 billion in 2025, then soared by 32.17% to $4.4 billion in 2026.
  • Business Quant data shows Total Liabilities for CORZ at $4.4 billion in Q1 2026, $3.3 billion in Q4 2025, and $3.4 billion in Q3 2025.